POC diagnostics has played a crucial role in the fight against COVID-19 and is critical to the success of the numerous mass vaccination programs that are underway right now.
In this episode of CM Conversations, I speak to Jonathan O’Halloran, who is CEO at QuantuMDx – a diagnostics company that’s sought to support the NHS and UK throughout the pandemic by scaling up its Q-POC rapid POC testing device.
Together, we discuss the future of POC Diagnostics, the role it has to play in helping the world return to normality and the trends that Jonathan believes will be influential over the next 12 to 18 months.
If you’d rather read about this topic, I’ve condensed this conversation into an article: “What's Next for POC Diagnostics?”
For more content like this or information about myself, please go to my CM Life Science profile page.
Any questions? Feel free to email me at Nathan.Sharpe@lifesci-cm.com.
Alongside the growing trend of value-based searches, I wanted to delve into why candidates prioritise companies that focus on fundamental principles and ethics which resonate with them, as opposed to other more material benefits. Find out why, here.
In this episode, Jack speaks with two Co-Founders at Centivax about life as successful entrepreneurs, the journey to acquisition, challenges and learnings - and using them to become an industry-defining author. Listen now.
We've highlighted companies in the molecular diagnostics space who have gained access to funding in the molecular diagnostics space in the last 18 months.
Comments.